- Home
- Publications
- Publication Search
- Publication Details
Title
Positioning time in range in diabetes management
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-07
DOI
10.1007/s00125-019-05027-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Translating Glycated Hemoglobin A1c into Time Spent in Glucose Target Range: a Multicenter Study
- (2019) Jonathan Petersson et al. PEDIATRIC DIABETES
- Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
- (2019) Karl Kristensen et al. DIABETOLOGIA
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Associations between HbA 1c and continuous glucose monitoring‐derived glycaemic variables
- (2019) I. B. Hirsch et al. DIABETIC MEDICINE
- Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
- (2019) Helen R. Murphy DIABETOLOGIA
- Random plasma glucose predicts the diagnosis of diabetes
- (2019) Mary K. Rhee et al. PLoS One
- Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice
- (2018) Ramzi A Ajjan et al. Diabetes & Vascular Disease Research
- Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System
- (2018) Laurel H. Messer et al. DIABETES CARE
- Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
- (2018) DIABETES CARE
- A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
- (2018) Arndís F. Ólafsdóttir et al. Diabetes Technology & Therapeutics
- Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”
- (2018) David Rodbard Diabetes Technology & Therapeutics
- Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
- (2018) Thomas A. Peyser et al. Diabetes Technology & Therapeutics
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
- (2018) Richard M. Bergenstal et al. DIABETES CARE
- Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch
- (2018) Michael P. Stone et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
- (2018) Robert A. Vigersky et al. Diabetes Technology & Therapeutics
- When HbA1c and Blood Glucose Do Not Match: How Much Is Determined by Race, by Genetics, by Differences in Mean Red Blood Cell Age?
- (2018) Robert M Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
- (2017) Marcus Lind et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
- (2017) Roy W. Beck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FreeStyle Libre: contact irritation versus contact allergy
- (2017) Olivier Aerts et al. LANCET
- Cutaneous adverse events related to FreeStyle Libre device
- (2017) Nesrine Brahimi et al. LANCET
- Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
- (2017) Denice S Feig et al. LANCET
- Metrics for glycaemic control — from HbA1c to continuous glucose monitoring
- (2017) Boris P. Kovatchev Nature Reviews Endocrinology
- Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
- (2017) Thomas Haak et al. Diabetes Therapy
- Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
- (2017) Thomas Haak et al. Diabetes Therapy
- Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes
- (2016) Boris Kovatchev et al. DIABETES CARE
- Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets
- (2016) Molly L. Tanenbaum et al. DIABETES CARE
- Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
- (2016) Louis Monnier et al. DIABETES CARE
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
- (2016) Jan Bolinder et al. LANCET
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
- (2016) Thomas Haak et al. Diabetes Therapy
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
- (2016) Thomas Haak et al. Diabetes Therapy
- The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial
- (2015) James M. Hempe et al. DIABETES CARE
- Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
- (2015) Irl B. Hirsch DIABETES CARE
- Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!
- (2015) Richard M. Bergenstal DIABETES CARE
- Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
- (2015) Boris P. Kovatchev et al. Diabetes Technology & Therapeutics
- Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia
- (2014) P. E. Cryer DIABETES
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
- (2013) Richard M. Bergenstal et al. Diabetes Technology & Therapeutics
- Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
- (2011) R. A. Vigersky et al. DIABETES CARE
- Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring
- (2011) FREDERIEK E VOS et al. NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search